Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VLA15 (mv rOspA LB Vaccine) Phase 1/2 in Healthy Adults
NCT01504347Phase 2Completed
- Sponsor
- Takeda
- Start
- Mar 2011
- Primary completion
- Sep 2011
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 2
01
Overview
A Phase 2 trial of Lyme Disease Vaccine Recombinant OspA in Lyme disease, sponsored by Takeda. Started Mar 2011; status: completed.
02
Drugs
Lyme Disease Vaccine Recombinant OspA
03
Conditions
Lyme disease
Beyond the preview
Go deeper on NCT01504347.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01504347.